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Scientific studies focused on the role of the human microbiome over human health have
generated billions of gigabits of genetic information during the last decade. Nowadays
integration of all this information in public databases and development of pipelines
allowing us to biotechnologically exploit this information are urgently needed. Prediction
of the potential bioactivity of the products encoded by the human gut microbiome, or
metaproteome, is the first step for identifying proteins responsible for the molecular
interaction between microorganisms and the immune system. We have recently
published the Mechanism of Action of the Human Microbiome (MAHMI) database
(http://www.mahmi.org), conceived as a resource compiling peptide sequences with
a potential immunomodulatory activity. Fifteen out of the 300 hundred million peptides
contained in the MAHMI database were synthesized. These peptides were identified as
being encrypted in proteins produced by gut microbiota members, they do not contain
cleavage points for the major intestinal endoproteases and displayed high probability to
have immunomodulatory bioactivity. The bacterial peptides FR-16 and LR-17 encrypted
in proteins from Bifidobacterium longum DJ010A and Bifidobacterium fragilis YCH46
respectively, showed the higher immune modulation capability over human peripheral
blood mononuclear cells. Both peptides modulated the immune response toward
increases in the Th17 and decreases in the Th1 cell response, together with an induction
of IL-22 production. These results strongly suggest the combined use of bioinformatics
and in vitro tools as a first stage in the screening of bioactive peptides encrypted in the
human gut metaproteome.
Keywords: bacterial peptides, Th17 response, CD4 cytokines, flow cytometry, microbiome, gut metaproteome
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INTRODUCTION
The composition of the human microbiome has revealed strong
associations with human health. Alterations in the intestinal
microbial populations when compared to control groups,
denominated dysbiosis, are nowadays associated with several
diseases from intestinal and extraintestinal nature (Shreiner
et al., 2015). Modulation of the human microbiome in order
to balance the microbial populations toward a healthy situation
is a promising intervention to improve human health in the
framework of many diseases (Drew, 2016).
The human microbiome performs key metabolic roles such
as production of vitamins, short-chain fatty acids and other
essential compounds, digestion of several components of the diet
such as fibers, gut homeostasis maintenance and modulation
of the host immune response (O’Toole et al., 2017). Gut
microbiota and human cells communicate with each other
through surface-associate proteins or extracellular components,
in a dialog denominated molecular cross-talk (Hevia et al.,
2015). Moreover, bacteria structural components have their
own receptors in the innate immune system; in this way, the
constant fraction of the surface-associated flagellin is recognized
by Toll-like receptor 5 (TLR-5) and the cell-wall component
lipopolysaccharide by TLR-4 (Sanchez et al., 2011). These
ligands are denominated microbial associated molecular patterns
(MAMPs) and their recognizing counterparts on the human host
are termed pattern recognition receptors (PRRs). Recognition
and binding of MAMPs to PRRs triggers different intracellular
signalization pathways that led to changes on the surface
molecules of the immune cells and in their effector secretion
profiles, among interleukins and other cytokines (Ley et al.,
2006). The type, amount and temporal pattern of MAMP-PRR
interaction will finally determine the type of immune response
that can be roughly divided into proinflammatory (mainly Th1,
Th2 and Th17) or regulatory responses (Treg) (Ruiz et al.,
2016a).
Extracellular and surface-associated proteins of the gut
microbiota have been studied in the last years as candidates
responsible for part of the immunomodulatory action of
intestinal microorganisms, given that these proteins performs
important roles in the interaction with the host and the
environment (Ruiz et al., 2016b). Many of this research has
been focused on the identification of molecules responsible
for the expansion of Treg cells, a Tcell subset essential in the
maintenance of a controlled and low-grade inflammation status
of the gut mucosa (Levy et al., 2017). Few proteins involved
in gut homeostasis maintenance and produced by gut bacteria
have been identified so far. Faecalibacterium prausnitzii is a
bacterium whose absence from the human gut microbiome
is associated with Crohn’s Disease, and which produces a
small protein with anti-inflammatory properties by inhibiting
the proinflammatory NF-κB pathway (Quevrain et al., 2016).
Lactic acid bacteria are transitory members of the human gut
microbiota in individuals with fermented product intake within
their diets. It has been shown that some lactobacilli species
are able to produce immunomodulatory peptides encrypted
in larger extracellular proteins. One of these peptides is
STp, which when recognized by dendritic cells isolated from
Ulcerative Colitis patients induced a switch toward an anti-
inflammatory cytokine profile (Bernardo et al., 2012; Al-Hassi
et al., 2014).
Therefore, the protein content of an intestinal microorganism
may play a key role in the way it modulates the immune
system functions in the host (Furusawa et al., 2015). Identifying
the molecules responsible for all the molecular crosstalk
mechanisms as well as the immune receptors/signalization
pathways induced/repressed by the different MAMPs are
needed for understanding the immune mechanism of
action of a gut microbiota taken as a whole. With these
limitations in mind, our research group has developed the
Mechanism of Action of the Human Microbiome (MAHMI)
database1 (Blanco-Miguez et al., 2017). MAHMI is an online
resource for the prediction of peptide bioactivity based
on their amino acid sequence which is fuelled by public
Metahit project metagenomes2. This database is a unique
resource for the organization and processing of potential
immunomodulatory peptides encrypted in the human gut
metaproteome.
In this work, we have identified 15 potential bioactive peptides
through MAHMI pipeline, to test whether this database was
able to identify potential immunomodulatory peptides. The in
silico test was completed with an in vitro test where 15 peptides
were incubated with human peripheral blood mononuclear cells
(PBMCs), and coupled to a multiplex secreted cytokine assay.
Main results are discussed next.
MATERIALS AND METHODS
Ethics approval for this study (reference code AGL2013-44039-R)
was obtained from the Regional Ethics Committee for Clinical
Research (Comité de Ética de la Investigación del Principado
de Asturias) in compliance with the Declaration of Helsinki.
Samples used in this study were obtained from anonymous
donors of our blood donation system.
Bioactivity Prediction
The bacterial peptides used in this study were previously selected
regarding their theoretical bioactivity based on in silico analyses
performed through the MAHMI database1 (Blanco-Miguez et al.,
2017). Briefly, the pipeline starts with the in silico digestion of
the proteins obtained from the human gut microbiome (gut
metaproteome). Potential bioactivity of the encrypted peptides
is performed by comparison of their amino acid sequence to
a curated database of immunomodulatory peptides. Selected
peptides (Table 1) were synthesized at GeneCust facilities
(Ellange, Luxemburg). Peptides were resuspended in phosphate
buffered saline (PBS) (Oxoid Limited, Hampshire, United
Kingdom) at a concentration of 2 mg mL−1 and stored at−80◦C
until their use.
1http://www.mahmi.org
2http://gigadb.org/dataset/100064
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Peripheral Blood Mononuclear Cells
(PBMC) Isolation
The capability of synthetic bacterial peptides to induce immune
modulation in vitro was assessed using a PBMC model. PBMCs
were isolated from the buffy coat of 5 healthy donors from
the Community Center for Blood and Tissues of Asturias
(Oviedo, Spain). Then, 5 mL of each buffy were diluted with
one volume of PBS and added on the top of a 5 mL of
Ficoll-Hypaque (Lymphoprep; Nycomed, Oslo, Norway) for
gradient separation. Cells were separated by centrifugation
(1,800 rpm, 30 min) with two further washes with PBS;
the first one at 1,200 rpm, 10 min (to discard platelets)
and the second one at 1,500 rpm, 5 min. The number of
PBMCs was estimated using a Neubauer chamber (Brand,
VWRI Eurolab, Barcelona, Spain) and adjusted to a final
concentration of 2 × 106 mL−1 in RPMI 1640 broth (Lonza,
Basilea, Switzerland) supplemented with 10% (v/v) fetal bovine
serum and antibiotics (Sigma-Aldrich, San Luis, MO, United
States).
Co-cultivation of Peptides and PBMCs
Peripheral blood mononuclear cells were cultivated in round
bottom 96 wells microplates using 200 µL of the cell suspension
described above. Bacterial peptides were added at a final
concentration of 50 µg mL−1, based on previous studies of
the immunomodulatory peptide STp (Bernardo et al., 2012).
PBMCs were activated with 100 ng mL−1 of anti-CD3 added
to the RPMI media. For each donor positive (LPS, 1 µg
mL−1) and negative controls of PBMCs stimulation were
included. Microplates were incubated for 5 days at 37◦C with
5% CO2.
Cytokine Quantification
After 5 days, supernatant was collected and stored at
−80◦C for multiplexed cytokine analyses. The production
of 18 different cytokines (GM-CSF, IFNγ, IL-1β, Il-2, IL-4,
IL-5, IL-6, IL-9, IL-10, IL-12p70, IL-13, IL-17A, IL-18,
IL-21, IL-22, IL-23, IL-27, and TNFα) were quantified
using the Th1/Th2/Th9/Th17/Th22/Treg Cytokine 18-Plex
Human ProcartaPlexTM Panel (Affymetrix eBioscience,
San Diego, CA, United States) and the Luminex R© xMap
Technology equipment following manufacturer’s settings. The
results for each cytokine were represented using box plot
diagrams and differences between peptides were statistically
analyzed.
In the case of peptides FR-16 and LR-17, the following ratios
were calculated for each sample: IL10/TNFα, IL10/IFNγ,
IL10/IL17, IL10/IL4, IFNγ/IL17, Th1/Th2, Th17/Th1,
Th17/Th2, Th1/Treg, Th2/Treg, Th1 + Th2 + Th17/Treg,
Th17/Treg, Th22/Th1, Th22/Th2, Th22/Th17, Th22/Treg
and Th22 + Th17/Th1 + Th2. These ratios were calculated
considering the T-cell response cytokines, either signature or
induced cytokines (Figure 1) and represented using boxplots.
Cytokines were included in each ratio according to the review of
Wan and Flavell with the addition of the Th22 subset (Wan and
Flavell, 2009).
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FIGURE 1 | Schematic representation of the main CD4+ effector T cells and their inducing/signature cytokines. Ratios calculated in this work were calculated taken
into account this distribution. ∗These cytokines were not included in the ratios as TGFβ and TNFβ have not been quantified.
Statistical Analyses
All experiments were performed in independent biological
quintuplicates. Data distribution did not follow normality, so
initial comparisons were performed with the non-parametric
Wilcoxon and Tukey pairwise tests. Differences in the value ranks
between two conditions were assessed with the Mann–Whitney
U tests for equal medians with Monte Carlo permutations
(n= 99,999). Comparisons with a p-value≤ 0.05 were considered
statistically significant. Whisker and boxes plots were generated
using ggplot2 in R environment, Past3 v3.15 (Hammer et al.,
2001) and the IBM SPSS Statistics package (SPSS Inc., Chicago,
IL, United States).
RESULTS AND DISCUSSION
In the present work we have synthesized 15 peptides (Table 1)
encrypted in proteins produced by the human gut microbiome
and selected due to their high potential immune modulatory
properties predicted through the MAHMI pipeline3. To
determine the immune response elicited by these bacterial
peptides we selected an in vitro PBMC model from human
healthy donors, as monocyte-derived dendritic cells have been
shown as not suitable for these purposes (unpublished data).
Eighteen cytokines related to T-cell response were quantified
in the PBMC supernatants of five healthy donors after 5 days
of co-culture with the peptides. Cytokine levels were measured
basally (PBMCs without anti-CD3), in the activation control
(PBMCs with anti-CD3), in the positive control (LPS+ activated
PBMCs) and for each peptide of study (peptide + activated
PBMCs) (Supplementary Figure S1).
In general every peptide was sensed by PBMCs, which reacted
with changes in their secreted cytokine profiles compared to
the activation control. All the peptides displayed an effect
3http://www.mahmi.org
modulating the production of at least one cytokine, although
few of them induced consistently the production of interleukins
from single T-cell response pathways, represented in Figure 1.
For instance, the production of IL-2 and IL-6 were statistically
induced (p < 0.05) by peptides FR-16, LR-17, AR-15, EY-12,
KE-13 when compared to the control, as well as the LPS
(Supplementary Figure S1). Peptides FR-16 and LR-17, with an
immunomodulatory bioactivity prediction in MAHMI database
of 100 and 80% respectively (Table 1), showed the higher immune
modulation capability as reflected in the cytokine secretion
induced over PBMCs (Figure 2).
FR-16 and LR-17 are bacterial peptides encrypted in proteins
from Bifidobacterium longum DJ010A and Bacteroides fragilis
YCH46, species that are amongst the more abundant members
of the human microbiome (Arboleya et al., 2016; Lloyd-Price
et al., 2016). As shown in Figure 2, both peptides increased the
production of IL-6, IL17a, IL12p70, IL22, IL23 and TNFα either
significantly or at the same levels than LPS did (with p-values very
close to 0.05). All these cytokines are important in the Th17 and
Th22 differentiation pathways (Wan and Flavell, 2009).
As the T cell response in our model seemed to be modulated
by FR16 and LR17, different ratios were calculated taken
into account the inducing and signature cytokines for each
pathway and also key cytokines such as IL10, TNFα or IFNγ
(Supplementary Figure S2). As it can be shown in Figure 3, the
Th17/Th1 and the Th17/Th2 ratio was consistently higher for
both peptides compared with the anti-CD3 activation control.
When Th22/Th1 and Th22/Th17 ratios were computed, the basal
conditions were displaced toward the Th22 pathway and addition
of the anti-CD3 antibody induced production of both Th1 and
Th17 cytokines. Interestingly, increase in the Th22 pathway was
significantly higher for both peptides whatever the pathway used
for calculate the ratio, and always compared to the activation
control.
Th17 and Th22 response develop important roles in the
maintenance of gut homeostasis. In general, it has been reported
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FIGURE 2 | Main cytokine levels affected by the presence of peptides LR17 and FR16. Boxplots represent median and interquartile range for the selected cytokines
(see all in Supplementary Figure S1). These were quantified in the supernatants after 5 days of in vitro co-culture of human PBMCs and the bacterial peptides
FR-16 and LR-17, from B. longum DJO10A and B. fragilis YCH46, respectively. Significant differences were assessed by the non-parametric Mann–Whitney U test
and are represented with ∗, ∗∗, or ∗∗∗ (p < 0.05, 0.01, or 0.001 respectively). Significant differences refer to control conditions (PBMCs + anti-CD3).
that commensal microbiota influence the balance between
Th1/Th2 (Ventura et al., 2012). Some probiotic bacteria possess
immunomodulatory properties either by acting over immune cell
populations and epithelial cells. This is the case of the yogurt
starter Lactobacillus delbrueckii subsp. bulgaricus 8481 which
reduced the concentration of cytokine IL-8 in serum following
yogurt consumption. IL8 is an important pro-inflammatory
chemokine produced by epithelial cells (and also macrophages)
with induces chemotaxis in many immune cells, attracting them
to infection sites (Moro-Garcia et al., 2013).
In bifidobacteria, the capability to induce different immune
responses is a strain-dependent trait (Lopez et al., 2010), and for
instance B. bifidum LMG13195 is able to induce Treg response
(Lopez et al., 2011). On the other hand, surface proteins like
the sortase-dependent pili from B. bifidum PRL2010 induced
a Th1 response (Turroni et al., 2013). Other surface-associated
protein are more related in regulating inflammatory responses
such as Lactobacillus acidophilus S-layer A, which has been
shown to protect mouse against experimentally induced colitis
through a specific interaction with SIGNR3 (Lightfoot et al.,
2015). Treg cells have become one of the main focuses of
study in immune modulation properties of probiotics, and the
balance between Treg/Th responses plays a key role in the
maintenance of gut homeostasis (Maloy and Powrie, 2011).
Treg induction has been previously demonstrated for where
the surface associated proteins may play a key role. In our
study, no significant differences were found regarding Treg cell
differentiation induction by our selected peptides. However,
interleukin 2 was upregulated by peptides FR-16 and LR-17
(and other peptides) (Supplementary Figure S1). IL-2 is directly
related with Treg proliferation and maintenance of the subset
population, and indeed Treg cells express the receptor for IL-2
(which is CD25) (Boyman and Sprent, 2012).
Expansion of Th17 cells is characteristic of segmented
filamentous bacteria, which inhabits the murine gut and whose
presence is directly linked with this specific T cell response
(Ivanov et al., 2009; Farkas et al., 2015). Indeed presence of these
bacteria confers resistance to the intestinal pathogen Citrobacter
rodentium (Ivanov et al., 2009). There is strong scientific evidence
of the key role of the gut microbiota in Th17 differentiation to
promote a balance in the immune response to ensure a healthy
status (Ivanov et al., 2008). In general, the Th17 pathway serves as
protection against extracellular pathogens through recruitment
of neutrophils (IL-17) and induction of anti-microbial peptides
(IL-22). Th17 cells contribute to the resistance and the clearance
of different enteropathogens such as Salmonella or Listeria, but
also for airways pathogens such as Klebsiella pneumoniae (Happel
et al., 2005; Kleinschek et al., 2006).
IL-22 is the signature cytokine of the Th22 cell subset and it
has been related with the maintenance of the intestinal epithelium
(tissue regeneration and cell proliferation) and contributing to
the mucosal integrity ensuring the intestinal barrier function
against pathogens (Rutz et al., 2014). It has also a role regulating
CD4+ T cell response to commensal bacteria (Parks et al., 2016).
One of the main roles of Th22 cells is to keep the epithelial barrier
and reinforce it against potential pathogens such as Clostridium
difficile (Hasegawa et al., 2014). IL-22 develops also important
roles in intestinal epithelial cell proliferation and survival, two
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FIGURE 3 | Ratios affected by the presence of peptides LR17 and FR16. Boxplots represent median and interquartile range for the ratios (see all in Supplementary
Figure S2). Significant differences were assessed by the non-parametric Mann–Whitney U test and are represented with ∗, ∗∗, or ∗∗∗ (p < 0.05, 0.01, or 0.001
respectively). Significant differences refer to control conditions (PBMCs + anti-CD3).
factors that are compromised in the course of an infection, and
IL-22 is mainly produced by Th17 cells, Innate Lymphoid Cells,
γδ T cells, and Natural Killer T cells (Ouyang et al., 2011). Human
Th22 cells are characterized by producing low amounts of IL-17
and differenciate from naïve CD4+ T cells with IL-6 and without
TGF-β (Zheng et al., 2007).
LR-17 but not FR-16 induced production of GM-CSF and
IL-1β, very similar to the action of LPS over PBMCs (Figure 4).
These suggests that LR-17 action could be related to macrophage
activation, which are important cells in inflammation with
roles including elimination of pathogens and debris clearance.
Macrophages show high degree of functional plasticity and
may acquire different roles depending on the activation signals.
It is well known that IFNγ-activated macrophages (Th1) are
pro-inflammatory and antimicrobial, and their dysregulation is
key in development of several inflammatory disorders, whereas
IL4/IL13-activated macrophages (Th2) have anti-inflammatory
roles (Arnold et al., 2015). Macrophages are very abundant in
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FIGURE 4 | Proposed mechanism of action of LR17 and FR16 over the human immune system as supported by cytokine measurement. Significant differences were
assessed by the non-parametric Mann–Whitney U test (∗∗p< 0.01). Significant differences refer to control conditions (PBMCs + anti-CD3).
the inflammation sites, and indeed their numbers correlate with
Th17 activity, contrarily to other antigen presenting cells such
as dendritic cells (Allam et al., 2011). High amounts of IL-1β
were produced in the presence of LR-17, but not in the presence
of FR-16. IL-1β is produced by activated macrophages and is
an important mediator of the inflammatory response and for
Th17 expansion (Lasiglie et al., 2011), supporting Th17 expansion
through macrophage activation as the mechanism of action of
LR-17. In fact, the higher concentration of IL-1β induced by LR-
17 correlates with the higher amounts of IL-22 detected, as the
former induce Th17 cells to produce IL-22 (Monteiro et al., 2013).
Finally this suggests the existence of a specific LR-17 receptor
on antigen presentation cells, although this hypothesis deserves
further research.
Why LR-17 and not FR-16 activated macrophages is out of the
scope of our experimental setup. Strains of the species Bacteroides
fragilis are known for the production of Polysaccharide A
(PSA), an extracellular glycan with anti-inflammatory properties
(Mazmanian et al., 2008), but many other surface components
have been shown to possess immunomodulatory activity (Wexler
and Goodman, 2017). On the contrary, higher abundances of
commensal bifidobacteria are linked to Treg promoting pathways
(Lopez et al., 2012), and many of the probiotic products targeting
intestinal inflammatory disorders contain bifidobacteria (Ng
et al., 2010). The cellular type targeted by bifidobacterial FR-16
peptide remains a mystery.
It must be considered that dysregulation of both Th17 and
Th22 pathways are linked to inflammatory and autoimmune
diseases. For instance higher production of IL-22 in the
colonic mucosa has been observed in patients suffering from
inflammatory bowel disease (Parks et al., 2016), and a pathogenic
role for the overproduction of this cytokine has been proposed in
rheumatoid arthritis (Rutz et al., 2014). However, increasing the
Th17 response may be protective in other autoimmune diseases
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such as type 1 diabetes, so this type of encrypted peptides could
have an application in the remission of these disorders (Sanchez
et al., 2015). In addition, in vivo studies suggest that infection
by Citrobacter rodentium in IL-23 -/- mice can be prevented by
transferring Th22 but not Th17 cells (Basu et al., 2012). Further
research will elucidate precisely the mechanism of action of this
type of peptides over CD4+ effector T cells.
CONCLUSION
All bacterial peptides analyzed in this study were able to
modulate, in vitro, the immune response of human PBMCs, based
on the cytokine pattern production. These results corroborated
the in silico prediction performed with MAHMI database
showing the usefulness of this tool to make accurate prediction
for a screening in the selection of bioactive peptides. Results
obtained for these peptides using human PBMCs strongly
suggested that these Th17-promoting peptides might be detected
by specific receptors, although this is a speculative statement
deserving further experiments. The peptides FR-16 and LR-17,
encrypted within the human gut metaproteome, were able to
induce a higher immune response that is related with Th17
and Th22 responses. Incubation of these peptides with PBMCs
allowed us to test the hypothesis of whether our gut microbiota
is able to interact with the immune system through peptides
encrypted in larger proteins. We propose the possibility to use
bacterial peptides encrypted in the human microbiome proteins,
as key inductors to modulate the human immune response for
several immunological disorders, as recently reviewed (Blanco-
Míguez et al., 2016).
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